QuantRx Biomedical Corporation (QTXB)

USD 0.0

(400.0%)

Annual Income Statements

(In USD)
Breakdown 2022 2021 2020 2019 2018 2017
Revenue - - - - - -
Cost of Revenue - - - - - 10.85 Thousand
Gross Profit - - - - - -10.85 Thousand
Operating Expenses - 43.38 Thousand 60.62 Thousand 201.73 Thousand 235.87 Thousand 165.17 Thousand
Selling, General and Administrative Expenses - 43.38 Thousand 60.62 Thousand 201.73 Thousand 235.87 Thousand 154.31 Thousand
Research and Development Expenses - - - - - -
Other Expenses - - 24.61 Thousand - 100.26 Thousand 4682.00
Cost and Expenses - 43.38 Thousand 60.62 Thousand 201.73 Thousand 235.87 Thousand 165.17 Thousand
Operating Income - -43.38 Thousand -60.62 Thousand -201.73 Thousand -235.87 Thousand -165.17 Thousand
Interest Expense - 216.65 Thousand 216.72 Thousand 198.18 Thousand 232.16 Thousand 245.41 Thousand
Income Tax Expense - 216.65 Thousand 216.72 Thousand 198.18 Thousand 601.23 Thousand 1.27 Million
Earnings before Tax - -260.04 Thousand -252.73 Thousand -621.92 Thousand -736.85 Thousand 869.13 Thousand
Net Income - -476.7 Thousand -469.45 Thousand -820.1 Thousand -736.85 Thousand 869.13 Thousand
Earnings Per Share Basic - -0.01 -0.01 -0.01 -0.01 0.01
Earnings Per Share Diluted - -0.01 -0.01 -0.01 -0.01 0.01
Weighted Average Shares Outstanding - 78.69 Million 78.69 Million 78.69 Million 78.69 Million 78.69 Million
Weighted Average Shares Outstanding (Diluted) - 78.69 Million 78.69 Million 78.69 Million 78.69 Million 130.43 Million
Gross Margin - - - - - -
EBIT Margin - - - - - -
Profit Margin - - - - - -
EBITDA - -43.38 Thousand -36.01 Thousand -201.73 Thousand -225.02 Thousand -154.31 Thousand
Earnings Before Tax Margin - - - - - -

Income Statement Charts